Physician profile
Eric D Ervin
NPI 1225105596
$3,372.90
in general payments reported to CMS, 2019-2025
17 companies · $556 in 2025
The $556 reported for 2025 was more than what 95% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $478 · 2020: $228 · 2021: $425 · 2022: $313 · 2023: $484 · 2024: $890 · 2025: $556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,930.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,929.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $1,039.55 | 2021-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $559.83 | 2021-2025 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $363.32 | 2019-2024 | Jornay Pm |
| Tris Pharma INC | $314.82 | 2019-2025 | Dyanavel Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $237.89 | 2020-2022 | |
| Glaxosmithkline, LLC. | $211.52 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $201.81 | 2025 | Jornay Pm |
| Shire North American Group INC | $84.11 | 2019 | |
| Pfizer INC. | $82.61 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $70.23 | 2021-2024 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Neos Therapeutics, Lp | $51.63 | 2019-2021 | |
| Sanofi Pasteur INC. | $37.61 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $33.22 | 2024 | Flumist Quadrivalent |
| Sarepta Therapeutics, INC. | $29.06 | 2024 | |
| Sobi, INC | $27.39 | 2022-2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $14.71 | 2024 | Relexxii |
| Teva Pharmaceuticals USA, INC. | $13.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Ervin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.